Showing results (1221-1230 of 1,876) with videos related to
Sort By:
Pageof 188
Open Heart|August 2, 2017
Time-based measures of treatment effect: reassessment of ticagrelor and clopidogrel from the PLATO trialAndrea Bellavia, Lars Wallentin, Nicola Orsini, et al.Open Heart|August 2, 2017
The safety, efficacy and cost-effectiveness of stress echocardiography in patients with high pretest probability of coronary artery diseaseAlexandros Papachristidis, Daniela Cassar Demarco, Damian Roper, et al.Open Heart|August 2, 2017
Mortality and oral anticoagulants in the Food and Drug Administration Adverse Event Reporting SystemVictor Serebruany, Vasily Cherepanov, Seth Fortmann, et al.Open Heart|October 31, 2017
Dual antiplatelet therapy for secondary prevention of coronary artery diseaseSophie Degrauwe, Thomas Pilgrim, Adel Aminian, et al.Open Heart|November 10, 2017
Association of QT interval with mortality by kidney function: results from the National Health and Nutrition Examination Survey (NHANES)Rehan Malik, Sehrish Waheed, Deepak Parashara, et al.Open Heart|September 8, 2017
High-pitch versus conventional cardiovascular CT in patients being assessed for transcatheter aortic valve implantation: a real-world appraisalTevfik F Ismail, Emma Cheasty, Laurence King, et al.Open Heart|September 16, 2017
Cardiometabolic effects of a novel SIRT1 activator, SRT2104, in people with type 2 diabetes mellitusRadzi M Noh, Sowmya Venkatasubramanian, Shruti Daga, et al.Open Heart|May 14, 2016
Plasma brain natriuretic peptide concentrations in patients with valvular heart diseaseVishal Sharma, Ralph A Stewart, Mildred Lee, et al.Open Heart|May 10, 2016
Interpreting angina: symptoms along a gender continuumCatherine Kreatsoulas, Mary Crea-Arsenio, Harry S Shannon, et al.Open Heart|May 31, 2016
Effects of the small molecule SIRT1 activator, SRT2104 on arterial stiffness in otherwise healthy cigarette smokers and subjects with type 2 diabetes mellitusSowmya Venkatasubramanian, Radzi M Noh, Shruti Daga, et al.Pageof 188